Experiment 989501

Details

PropertyValue
Pharmacology
OrganismEmpty organism
CitationKANE,RC: COHEN,MH: BRODER,LE: BULL,MI: CREAVEN,PJ: FOSSIECK JR,BE:. (1975). PHASE I-II EVALUATION OF EMETINE (NSC-33669) IN THE TREATMENT OF EPIDERMOID BRONCHOGENIC CARCINOMA.. 59()
Amount utilized
Compound isolated
DiseasePHASE I-II CLINICAL STUDY IN 15 SUBJECTS (45-65 YEARS OF AGE) WITH CONFIRMED EPIDERMOID BRONCHOGENIC CARCINOMA. ALL WERE INOPERABLE. USUAL DOSING WAS WEEKLY FOR 4-9 WEEKS. ALL PATIENTS COMPLETED AT LEAST 4 WEEKS OF THERAPY. CUMULATIVE DOSE-RELATED TOXICITY SEEN, ESPECIALLY AT DOSES HIGHER THAN 100-130 MG.SQ METER.
Dose amount75.0 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderMALE